Adam Rogers, MD, President and Chief Executive Officer of NervGen to present and discuss clinical data from the Phase 1b/2a CONNECT SCI Study demonstrating durable improvement in function, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results